Teixeira Farinha, H.; Digklia, A.; Schizas, D.; Demartines, N.; Schäfer, M.; Mantziari, S.
Immunotherapy for Esophageal Cancer: State-of-the Art in 2021. Cancers 2022, 14, 554.
https://doi.org/10.3390/cancers14030554
AMA Style
Teixeira Farinha H, Digklia A, Schizas D, Demartines N, Schäfer M, Mantziari S.
Immunotherapy for Esophageal Cancer: State-of-the Art in 2021. Cancers. 2022; 14(3):554.
https://doi.org/10.3390/cancers14030554
Chicago/Turabian Style
Teixeira Farinha, Hugo, Antonia Digklia, Dimitrios Schizas, Nicolas Demartines, Markus Schäfer, and Styliani Mantziari.
2022. "Immunotherapy for Esophageal Cancer: State-of-the Art in 2021" Cancers 14, no. 3: 554.
https://doi.org/10.3390/cancers14030554
APA Style
Teixeira Farinha, H., Digklia, A., Schizas, D., Demartines, N., Schäfer, M., & Mantziari, S.
(2022). Immunotherapy for Esophageal Cancer: State-of-the Art in 2021. Cancers, 14(3), 554.
https://doi.org/10.3390/cancers14030554